AIC Zoom Videoconference Venture Capital: Technology Investing in Switzerland and Abroad Featuring Pär Lange, Investment Partner of Swisscom Ventures and Michèle Ollier, Partne…
AIC Zoom Videoconference Venture Capital: Technology Investing in Switzerland and Abroad Featuring Pär Lange, Investment Partner of Swisscom Ventures and Michèle Ollier, Partne…
AIC Zoom Videoconference
Venture Capital: Technology Investing in Switzerland and Abroad
Featuring Pär Lange, Investment Partner of Swisscom Ventures and Michèle Ollier, Partner & Co-founder of Medicxi
Thursday, December 10th, 12 noon to 1:30pm
This will be a highly interactive call, where all can participate.
To join us – all you have to do is click on the Zoom invitation below on Thursday, December 10 and we will see you there.
Meeting ID: 826 0670 6418 Passcode: 922731
In association with:
NB: approximately the first ten minutes will be dedicated to the AIC Annual General Meeting.
Points of Contact: Ruth Dyson, admin@amclub.ch, Ed Schneider, edschneider4@gmail.com
Dr. Michèle Ollier is the Partner and Co-founder of Medicxi, a life science investment firm. Prior to forming Medicxi in 2016, Michèle was a Partner at Index Ventures for ten years. She has led investments in, and continues to serve on the boards of, several leading biotech companies.
Prior to joining Index, Michèle was Investment Director at Edmond de Rothschild Investment Partners in Paris for three years. Before that, she spent more than fifteen years in several development and marketing positions at Sanofi International, BMS, RPR/ Gencell/ Aventis International and Serono International.
She currently serves on the board of directors of Ipsen Pharmaceuticals. She also sits on the investment committees of the accelerator and technology transfer companies of Paris-Saclay and France-Nord. She advises the Robertson Therapeutic Development Fund at the Rockfeller University in New York City.
Michèle earned an MD from Paris-Ouest University.
Thu, Dec. 10, 2020
noon - 1:30 p.m.
(GMT+0200) Europe/Zurich